892 related articles for article (PubMed ID: 8709127)
1. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
[TBL] [Abstract][Full Text] [Related]
3. Pyrrolo[2,1-c][1,4]benzothiazines: synthesis, structure-activity relationships, molecular modeling studies, and cardiovascular activity.
Campiani G; Garofalo A; Fiorini I; Botta M; Nacci V; Tafi A; Chiarini A; Budriesi R; Bruni G; Romeo MR
J Med Chem; 1995 Oct; 38(22):4393-410. PubMed ID: 7473567
[TBL] [Abstract][Full Text] [Related]
4. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
[TBL] [Abstract][Full Text] [Related]
5. [3H]TA-3090, a selective benzothiazepine-type calcium channel receptor antagonist: in vitro characterization.
Zobrist RH; Mecca TE
J Pharmacol Exp Ther; 1990 May; 253(2):461-5. PubMed ID: 2338642
[TBL] [Abstract][Full Text] [Related]
6. Research on compounds with psychotropic activity. IX--Synthesis of 6-p-methoxyphenylpyrrolo[2,1-d][1,5]benzothiazepines and evaluation of their affinities for BDZ and GABA receptor subtypes.
Nacci V; Fiorini I; Garofalo A; Cagnotto A
Farmaco; 1990 May; 45(5):545-58. PubMed ID: 2171544
[TBL] [Abstract][Full Text] [Related]
7. High-affinity binding of DTZ323, a novel derivative of diltiazem, to rabbit skeletal muscle L-type Ca++ channels.
Hagiwara M; Adachi-Akahane S; Nagao T
J Pharmacol Exp Ther; 1997 Apr; 281(1):173-9. PubMed ID: 9103495
[TBL] [Abstract][Full Text] [Related]
8. Novel ligands specific for mitochondrial benzodiazepine receptors: 6-arylpyrrolo[2,1-d][1,5]benzothiazepine derivatives. Synthesis, structure-activity relationships, and molecular modeling studies.
Fiorini I; Nacci V; Ciani SM; Garofalo A; Campiani G; Savini L; Novellino E; Greco G; Bernasconi P; Mennini T
J Med Chem; 1994 May; 37(10):1427-38. PubMed ID: 8182701
[TBL] [Abstract][Full Text] [Related]
9. L-Type calcium channel blockers: from diltiazem to 1,2,4-oxadiazol-5-ones via thiazinooxadiazol-3-one derivatives.
Budriesi R; Cosimelli B; Ioan P; Ugenti MP; Carosati E; Frosini M; Fusi F; Spisani R; Saponara S; Cruciani G; Novellino E; Spinelli D; Chiarini A
J Med Chem; 2009 Apr; 52(8):2352-62. PubMed ID: 19323482
[TBL] [Abstract][Full Text] [Related]
10. Comparison of binding affinities and negative inotropic potencies of the 1,4-dihydropyridine calcium channel blockers in rabbit myocardium.
Boyd RA; Giacomini JC; Wong FM; Nelson WL; Giacomini KM
J Pharmacol Exp Ther; 1987 Oct; 243(1):118-25. PubMed ID: 2822893
[TBL] [Abstract][Full Text] [Related]
11. Functional and biochemical evidence for diazepam as a cyclic nucleotide phosphodiesterase type 4 inhibitor.
Collado MC; Beleta J; Martinez E; Miralpeix M; Domènech T; Palacios JM; Hernández J
Br J Pharmacol; 1998 Mar; 123(6):1047-54. PubMed ID: 9559885
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers.
Ramesh M; Matowe WC; Akula MR; Vo D; Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Knaus EE
J Med Chem; 1998 Feb; 41(4):509-14. PubMed ID: 9484501
[TBL] [Abstract][Full Text] [Related]
13. Voltage-dependent calcium channels in the rat retina: involvement in NMDA-stimulated influx of calcium.
Melena J; Osborne NN
Exp Eye Res; 2001 Apr; 72(4):393-401. PubMed ID: 11273667
[TBL] [Abstract][Full Text] [Related]
14. SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes.
Nokin P; Clinet M; Beaufort P; Meysmans L; Laruel R; Chatelain P
J Pharmacol Exp Ther; 1990 Nov; 255(2):600-7. PubMed ID: 2147036
[TBL] [Abstract][Full Text] [Related]
15. New antipsychotic agents with serotonin and dopamine antagonist properties based on a pyrrolo[2,1-b][1,3]benzothiazepine structure.
Campiani G; Nacci V; Bechelli S; Ciani SM; Garofalo A; Fiorini I; Wikström H; de Boer P; Liao Y; Tepper PG; Cagnotto A; Mennini T
J Med Chem; 1998 Sep; 41(20):3763-72. PubMed ID: 9748351
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, rotamer orientation, and calcium channel modulation activities of alkyl and 2-phenethyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(3- or 6-substituted-2-pyridyl)-5-pyridinecarboxylates.
Iqbal N; Akula MR; Vo D; Matowe WC; McEwen CA; Wolowyk MW; Knaus EE
J Med Chem; 1998 May; 41(11):1827-37. PubMed ID: 9599233
[TBL] [Abstract][Full Text] [Related]
17. Calmodulin antagonistic action of new 1,5-benzothiazepines derived from diltiazem.
Suzuki T; Ohashi M; Takaiti O; Harigaya S
Arzneimittelforschung; 1994 Jan; 44(1):3-6. PubMed ID: 8135875
[TBL] [Abstract][Full Text] [Related]
18. (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 1st communication: pharmacological profile.
Hofmann HP; Raschack M; Unger L
Arzneimittelforschung; 1989 Mar; 39(3):304-8. PubMed ID: 2757655
[TBL] [Abstract][Full Text] [Related]
19. The peripheral-type benzodiazepine receptor and the cardiovascular system. Implications for drug development.
Veenman L; Gavish M
Pharmacol Ther; 2006 Jun; 110(3):503-24. PubMed ID: 16337685
[TBL] [Abstract][Full Text] [Related]
20. Diltiazem-like calcium entry blockers: a hypothesis of the receptor-binding site based on a comparative molecular field analysis model.
Corelli F; Manetti F; Tafi A; Campiani G; Nacci V; Botta M
J Med Chem; 1997 Jan; 40(1):125-31. PubMed ID: 9016337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
